Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -35.84%6.12B | -47.81%4.01B | -57.73%1.64B | -24.23%11.77B | -18.64%9.54B | 0.37%7.68B | 10.60%3.88B | 4.97%15.53B | 21.89%11.72B | 46.50%7.65B |
| Operating revenue | -35.84%6.12B | -47.81%4.01B | -57.73%1.64B | -24.23%11.77B | -18.64%9.54B | 0.37%7.68B | 10.60%3.88B | 4.97%15.53B | 21.89%11.72B | 46.50%7.65B |
| Other operating revenue | ---- | 25.01%3.33M | ---- | 1.84%7.45M | ---- | 3.17%2.66M | ---- | 59.41%7.31M | ---- | 53.30%2.58M |
| Total operating cost | -35.54%6.04B | -47.58%3.95B | -57.26%1.64B | -24.75%11.48B | -18.70%9.37B | 0.36%7.54B | 10.82%3.85B | 5.14%15.26B | 21.66%11.52B | 46.68%7.51B |
| Operating cost | -37.26%5.67B | -49.41%3.7B | -59.14%1.52B | -25.05%11.04B | -18.92%9.04B | 0.69%7.31B | 11.13%3.73B | 4.94%14.72B | 22.37%11.15B | 48.50%7.26B |
| Operating tax surcharges | -32.22%13.04M | -34.94%8.54M | -45.60%3.63M | -32.44%26.57M | -39.26%19.23M | -46.26%13.13M | -54.11%6.67M | -9.80%39.33M | 1.32%31.67M | 49.28%24.43M |
| Operating expense | -13.25%13.78M | -22.45%8.34M | -26.63%4.27M | -19.47%23.23M | -29.96%15.88M | 14.99%10.76M | 17.88%5.82M | 4.19%28.85M | -4.03%22.67M | -40.16%9.35M |
| Administration expense | -1.09%142.92M | 5.78%96.05M | -7.60%48.42M | 2.43%194.42M | 1.72%144.49M | -0.69%90.8M | 11.39%52.4M | -6.45%189.81M | 0.55%142.04M | -0.01%91.43M |
| Financial expense | 77.21%152.08M | 73.29%113.63M | 41.17%56.15M | -36.03%123.86M | -36.31%85.82M | -27.42%65.57M | 3.46%39.77M | 21.76%193.63M | 3.79%134.74M | 7.87%90.34M |
| -Interest expense (Financial expense) | 66.43%149.58M | 67.46%114.92M | 28.25%54.66M | -39.17%129.6M | -38.05%89.87M | -29.57%68.63M | -2.59%42.62M | 16.78%213.06M | 2.92%145.08M | 7.44%97.43M |
| -Interest Income (Financial expense) | -0.44%-7.24M | 4.07%-4.89M | -8.58%-3.23M | 51.09%-10.2M | 36.70%-7.2M | 32.57%-5.1M | 53.49%-2.97M | 16.22%-20.86M | 26.67%-11.38M | 2.45%-7.56M |
| Research and development | -28.49%45.74M | -44.07%24.14M | -39.07%7.29M | -5.64%79.83M | 42.84%63.97M | 37.46%43.16M | 25.19%11.97M | 70.21%84.6M | 23.85%44.78M | 43.56%31.4M |
| Credit Impairment Loss | 10.69%-74.21M | 27.89%-52.68M | -44.10%-6.6M | -39.43%-150.65M | -37.85%-83.1M | -75.40%-73.06M | 86.22%-4.58M | -35.29%-108.04M | -81.36%-60.28M | -82.42%-41.65M |
| Asset Impairment Loss | 32.92%-6.77M | 287.27%20.84M | 138.64%5.84M | 29.69%-68.97M | 79.48%-10.1M | 74.75%-11.13M | -338.33%-15.12M | -24.11%-98.09M | -97.06%-49.22M | -5,034.85%-44.06M |
| Other net revenue | 18.18%-75.35M | 62.44%-31.43M | 97.81%-424.21K | -10.34%-211.57M | 15.58%-92.09M | 2.25%-83.67M | 27.79%-19.36M | -26.76%-191.75M | -93.34%-109.1M | -279.02%-85.6M |
| Invest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 123.72%1.51M | ---- | ---- |
| Asset deal income | -102.47%-14K | ---- | ---- | 48.84%-257K | 254.96%567.79K | 123.15%83.94K | 109.26%30.44K | -209.15%-502.3K | -208.33%-366.42K | -271.01%-362.52K |
| Other revenue | 960.20%5.65M | -5.10%415.84K | 7.56%330.81K | -37.90%8.31M | -30.72%532.91K | -9.42%438.18K | -20.24%307.55K | 105.92%13.38M | -46.96%769.17K | -46.06%483.73K |
| Operating profit | -92.42%5.95M | -56.25%25.51M | -114.45%-2.62M | -8.68%69.48M | -14.56%78.59M | 5.37%58.3M | 27.20%18.14M | -40.45%76.08M | 1.27%91.98M | -30.94%55.33M |
| Add:Non operating Income | -67.58%36.76K | -97.65%2.41K | -97.65%2.4K | -48.25%574.89K | -88.73%113.39K | -88.39%102.28K | -88.11%102.27K | -21.12%1.11M | 53.53%1.01M | 330.12%880.6K |
| Less:Non operating expense | -93.89%551.31K | -94.34%508.82K | 1,550.84%436.08K | -10.32%10.34M | 743.40%9.02M | 1,655.98%8.98M | -94.73%26.42K | 922.10%11.53M | -12.04%1.07M | -30.27%511.54K |
| Total profit | -92.19%5.44M | -49.42%25M | -116.77%-3.05M | -9.06%59.71M | -24.19%69.68M | -11.27%49.42M | 24.59%18.22M | -48.72%65.66M | 1.83%91.92M | -30.02%55.7M |
| Less:Income tax cost | -72.73%15.37M | -63.13%14.57M | -98.94%146.44K | 13.61%51.45M | 2.35%56.37M | 8.21%39.52M | 15.57%13.85M | -10.00%45.28M | 54.19%55.07M | 61.32%36.53M |
| Net profit | -174.59%-9.93M | 5.34%10.43M | -173.24%-3.2M | -59.45%8.26M | -63.87%13.31M | -48.37%9.9M | 65.48%4.37M | -73.79%20.37M | -32.45%36.85M | -66.33%19.18M |
| Net profit from continuing operation | -174.59%-9.93M | 5.34%10.43M | -173.24%-3.2M | -59.45%8.26M | -63.87%13.31M | -48.37%9.9M | 65.48%4.37M | -73.79%20.37M | -32.45%36.85M | -66.33%19.18M |
| Less:Minority Profit | ---3.78K | ---3.79K | ---- | ---- | ---- | ---- | ---- | -82.80%12.41M | -73.43%14.29M | -56.93%14.87M |
| Net profit of parent company owners | -174.56%-9.93M | 5.38%10.43M | -173.24%-3.2M | 3.76%8.26M | -40.98%13.31M | 130.02%9.9M | 144.67%4.37M | 43.33%7.96M | 2,846.71%22.56M | -80.80%4.3M |
| Earning per share | ||||||||||
| Basic earning per share | -183.33%-0.05 | 0.00%0.05 | -200.00%-0.02 | 0.00%0.04 | -45.45%0.06 | 150.00%0.05 | 140.00%0.02 | 33.33%0.04 | 2,650.00%0.11 | -81.82%0.02 |
| Diluted earning per share | -183.33%-0.05 | 0.00%0.05 | -200.00%-0.02 | 0.00%0.04 | -45.45%0.06 | 150.00%0.05 | 140.00%0.02 | 33.33%0.04 | 2,650.00%0.11 | -81.82%0.02 |
| Other composite income | ||||||||||
| Total composite income | -174.59%-9.93M | 5.34%10.43M | -173.24%-3.2M | -59.45%8.26M | -63.87%13.31M | -48.37%9.9M | 65.48%4.37M | -73.79%20.37M | -32.45%36.85M | -66.33%19.18M |
| Total composite income of parent company owners | -174.56%-9.93M | 5.38%10.43M | -173.24%-3.2M | 3.76%8.26M | -40.98%13.31M | 130.02%9.9M | 144.67%4.37M | 43.33%7.96M | 2,846.71%22.56M | -80.80%4.3M |
| Total composite income of minority owners | ---3.78K | ---3.79K | ---- | ---- | ---- | ---- | ---- | -82.80%12.41M | -73.43%14.29M | -56.93%14.87M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.